Use of dendritic cells (DCs) expressing interleukin 12 (IL-12)
Details for Australian Patent Application No. 2003260473 (hide)
International Classifications
Event Publications
20 November 2003 Complete Application Filed
Priority application(s): A 1375/2002 13.09.02 AT
20 May 2004 Application Open to Public Inspection
Published as AU-B-2003260473
7 August 2008 Application Accepted
Published as AU-B-2003260473
4 December 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003260472-SUBSTITUTED PYRIDINE DERIVATIVES AS ANTITUMOR AGENT
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser